The 88th Annual Meeting of the Japanese Society of Hematology (JSH)【Kyoto】

Meeting Theme

Bloodlines of Discovery: Generations in Hematology

The meeting aims to pass the knowledge and achievements established by previous generations of hematologists to the next generation while connecting fundamental and clinical research, scientific discovery and medical practice, different healthcare professions, and researchers in Japan and overseas.

Event Information

• Official Name: The 88th Annual Meeting of the Japanese Society of Hematology
• Japanese Name: 第88回日本血液学会学術集会
• Date: October 9 (Fri.)–11 (Sun.), 2026
• Main Venue: Kyoto International Conference Center
• Main Venue Address: 422 Iwakura Osagicho, Sakyo-ku, Kyoto 606-0001, Japan
• Additional Venue: The Prince Kyoto Takaragaike
• Additional Venue Address: 1092-2 Iwakura Hataedacho, Sakyo-ku, Kyoto 606-0015, Japan
• Meeting Format: Primarily an on-site meeting
• On-demand Access: Selected programs are scheduled for post-event on-demand streaming
• Organizer: Japanese Society of Hematology

Meeting Organization

• Congress President: Seiji Ogawa, Department of Tumor Biology, Graduate School of Medicine, Kyoto University
• Scientific Program Committee Chair: Toshihiro Miyamoto, Department of Hematology, Kanazawa University
• Scientific Program Committee Vice Chair: Takanori Teshima, Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University
• General Secretariat: Department of Tumor Biology, Graduate School of Medicine, Kyoto University
• Congress Secretariat: Japan Convention Services, Inc.

Abstract Submission

• Submission Period: February 12–May 7, 2026, at 12:00 noon JST
• Submission Status: Abstract submission has closed
• Acceptance Notification: Scheduled for August 2026
• Abstract Language: English
• Presentation Language: English or Japanese for general domestic submissions
• Presentation Formats: Oral presentation, poster presentation, and publication of accepted abstracts online
• Originality: Abstracts must contain original and unpublished research
• Abstract Title: Maximum of 100 characters, including spaces and punctuation, for overseas submissions
• Abstract Body: Maximum of 1,600 characters, including spaces and punctuation, for overseas submissions
• Figures and Tables: Charts, images, tables, and photographs are not accepted
• Ethical Review: Applicable studies must obtain the required IRB or ethical review approval before submission
• Conflict of Interest: The presenting author must disclose applicable relationships for all authors

Travel Awards for Overseas Researchers

• Award: JPY 100,000 and complimentary meeting registration
• Age Requirement: Applicants must be 45 years of age or younger on the first day of the meeting
• Residency Requirement: Applicants must be non-Japanese researchers residing in an Asian country outside Japan
• Authorship Requirement: Applicants must be the first author of an accepted abstract
• Academic Requirement: Applicants should have a demonstrated record of hematology research
• Application: Applicants were required to select the Travel Award option during abstract submission

Program Structure

• Presidential Lecture
• JSH Award Lecture
• ASH Special Lecture
• EHA Special Lecture
• Special Lectures
• Presidential Symposium
• Plenary Session
• JSH-ASH Joint Symposium
• JSH-EHA Joint Symposium
• Scientific Symposia
• Women Physicians Career Symposium
• Special Symposium
• JSH-EHA Travel Grant Awardee’s Session
• Asian Joint Panel Discussion
• Educational Lectures
• Scientific Exchange Training Program
• Clinical Debate

Special Lectures and International Programs

• ASH Special Lecture: Robert Negrin, Stanford University
• EHA Special Lecture: Konstanze Döhner, University Hospital of Ulm
• Special Lecture: Masashi Yanagisawa, International Institute for Integrative Sleep Medicine, University of Tsukuba
• Special Lecture: John E. Dick, Princess Margaret Cancer Centre and University Health Network
• JSH-ASH Joint Symposium: Recent Advances in Lymphoma Biology and Treatment Development
• JSH-EHA Joint Symposium: Advances in Research and Treatment of MDS
• Asian Joint Panel Discussion: Hematologic Malignancies in Adolescents and Young Adults

Featured Scientific Symposia

• Acute leukemia and recent advances in genetic, epigenetic, and molecular pathogenesis
• Artificial intelligence-assisted acceleration of hematopoiesis research
• New technologies and treatment strategies transforming leukemia research and care
• Recent molecular insights into the pathogenesis of bone marrow failure
• Minimal or measurable residual disease and post-transplant maintenance therapy
• Advances in the biology and treatment of myelodysplastic syndromes
• Recent advances in lymphoma biology and treatment development
• Personalized treatment strategies for multiple myeloma
• Bleeding disorders of unknown cause
• Cutting-edge research in CAR-T-cell therapy

Educational Lecture Topics

• Inherited anemia, paroxysmal nocturnal hemoglobinuria, and bone marrow failure
• Chronic active Epstein-Barr virus disease and inborn errors of immunity
• Long-read sequencing for hematologic malignancies
• Age-related clonal hematopoiesis and hematopoietic stem cell regulation
• Menin inhibitors and emerging therapies for acute myeloid leukemia
• Clinical and medical applications of generative artificial intelligence
• Genomic abnormalities and multi-omics analysis in multiple myeloma
• CAR-T-cell therapy for acute lymphoblastic leukemia and autoimmune diseases
• Genomic panel testing and precision medicine for hematologic malignancies
• Single-cell analysis of lymphoma
• iPS-cell models of hematologic disorders and therapeutic research
• Artificial production of red blood cells using cell-culture technologies
• GVHD biomarkers, infectious diseases, transfusion medicine, coagulation, and fibrinolysis

Scientific Exchange Training Program

The Scientific Exchange Training Program is designed to improve the English oral-presentation and discussion skills of early-career physicians and researchers. Experts invited from the American Society of Hematology provide guidance on presentation methods, scientific content, and responses during question-and-answer sessions.

• Eligible Presenters: JSH members aged 45 or younger
• Presentation: 10 minutes per presenter
• Feedback: Approximately 10–15 minutes per presenter
• SETP 1: Clinical Challenge for Leukemia
• SETP 2: Genomic Analysis for Hematologic Malignancy
• SETP 3: Stem Cell Biology
• SETP 4: Lymphoma

Selected International Speakers

• Stefanie R. Bailey
• Nancy L. Bartlett
• Monique den Boer
• Mario Cazzola
• Luciano Costa
• John E. Dick
• Hartmut Döhner
• Konstanze Döhner
• Ulrike Gerdemann
• Gregory M. Goldgof
• Eva Hellström Lindberg
• Steven Horwitz
• Elias Jabbour
• Mark J. Levis
• Charles Mullighan
• Satu Mustjoki
• Robert Negrin
• Aaron Newman
• Akiko Shimamura
• Timm Schroeder

Main Research and Clinical Areas

• Hematopoietic stem cells, hematopoietic development, and blood-cell differentiation
• Acute and chronic leukemia
• Malignant lymphoma
• Multiple myeloma and plasma-cell disorders
• Myelodysplastic syndromes and myeloproliferative neoplasms
• Aplastic anemia and bone marrow failure
• Pediatric hematologic disorders and inborn errors of immunity
• Hematopoietic stem cell transplantation and GVHD
• CAR-T-cell therapy and cellular immunotherapy
• Transfusion medicine, coagulation, thrombosis, and fibrinolysis
• Management of infectious diseases in hematology
• Genomics, gene-panel testing, and long-read sequencing
• Single-cell analysis, multi-omics, and artificial intelligence
• Clinical trials, precision medicine, and patient and public involvement

Childcare Service

• Location: Inside the Kyoto International Conference Center
• Eligible Children: Children aged six months through elementary-school age
• Capacity: 10 children
• Fee: Complimentary
• October 9: 8:30–19:00
• October 10: 8:00–19:30
• October 11: 8:00–16:45
• Application Deadline: September 25, 2026, at 17:00 JST
• Requirement: Meeting registration and payment must be completed before applying

Overview

The meeting will address disease mechanisms, diagnostic technologies, drug therapies, transplantation, cellular therapy, supportive care, and clinical practice across the field of hematology. It will also explore the application of artificial intelligence, generative AI, long-read sequencing, single-cell analysis, multi-omics, and iPS-cell technologies to hematology research and patient care. Under the theme “Bloodlines of Discovery: Generations in Hematology,” the meeting aims to preserve the achievements of previous generations while creating the future of hematology through international and multidisciplinary collaboration.

Publication Status

• Abstract Submission: Closed
• Abstract Acceptance Notification: Scheduled for August 2026
• Main Scientific Program: Published
• Invited Speakers: Published
• Online Registration: Under preparation
• Registration Fees: Under preparation
• Participant Information: Under preparation
• Abstract and Schedule Application: Under preparation
• Abstract Downloads: Under preparation
• Accommodation Information: Under preparation

Access to the Venues

• Kyoto Municipal Subway: Approximately five minutes on foot from Kokusaikaikan Station on the Karasuma Line
• From Kyoto Station: Approximately 20 minutes to Kokusaikaikan Station by the Karasuma Subway Line without changing trains
• Bus: Approximately five minutes on foot from Kokusaikaikan Station-mae bus stop
• The Prince Kyoto Takaragaike: Located adjacent to the Kyoto International Conference Center
• Main Venue Address: 422 Iwakura Osagicho, Sakyo-ku, Kyoto 606-0001, Japan

Official Links